General Information of the Compound
Compound ID
CP0176637
Compound Name
1-[(3S)-5-cyclohexyl-2,4-dioxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)-1,5-benzodiazepin-3-yl]-3-(4-fluorophenyl)urea
    Show/Hide
Synonyms
CHEMBL320141
GR-199114X
SCHEMBL14520869
    Show/Hide
Structure
Formula
C28H32FN5O4
Molecular Weight
521.593
Canonical SMILES
Fc1ccc(NC(=O)N[C@H]2C(=O)N(CC(=O)N3CCCC3)c3ccccc3N(C3CCCCC3)C2=O)cc1
    Show/Hide
InChI
InChI=1S/C28H32FN5O4/c29-19-12-14-20(15-13-19)30-28(38)31-25-26(36)33(18-24(35)32-16-6-7-17-32)22-10-4-5-11-23(22)34(27(25)37)21-8-2-1-3-9-21/h4-5,10-15,21,25H,1-3,6-9,16-18H2,(H2,30,31,38)/t25-/m0/s1
    Show/Hide
InChIKey
URMOKEJAUAGZGV-VWLOTQADSA-N
Physicochemical Property
logP
3.6507
Rotatable Bonds
5
Heavy Atom Count
38
Polar Areas
102.06
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
38

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9914672
SID: 14885136
ChEMBL ID
CHEMBL320141
Clinical Information about the Compound
Drug 1 ( GR-199114X )
Drug Name GR-199114X
Company Glaxo Wellcome plc
Indication
Stomach ulcer
Terminated
Target(s)
Gastrin/cholecystokinin type B receptor (CCKBR)
Modulator